Researchers at the University of Eastern Finland have discovered previously unknown non-coding RNAs involved in regulating the gene expression of vascular endothelial growth factors, the master regulators of angiogenesis.
According to a new study published in The American Journal of Human Genetics, more than one third of genetic variants that increase the risk of coronary artery disease regulate the expression of genes in the liver.
The risks of an elective revascularisation procedure for coronary artery disease are similar for people with and without Alzheimer’s disease (AD), but people with AD have worse outcomes after an emergency procedure.
Selected to the Academy of Finland’s Flagship Programme for the years 2020–2024, the GeneCellNano Flagship seeks to speed up the introduction of new biological drugs for severe chronic diseases. The Flagship is led by Academy Professor Seppo Ylä-Herttuala.